Showing 2,241 - 2,260 results of 2,268 for search '"Polycystic ovary syndrome"', query time: 0.13s Refine Results
  1. 2241

    Effects of maternal characteristics and medical history on first trimester biomarkers for preeclampsia by Johnatan Torres-Torres, Johnatan Torres-Torres, Salvador Espino-y-Sosa, Salvador Espino-y-Sosa, Jose Rafael Villafan-Bernal, Jose Rafael Villafan-Bernal, Luis Enrique Orozco-Guzman, Juan Mario Solis-Paredes, Guadalupe Estrada-Gutierrez, Romeo Adalid Martinez-Cisneros, Paloma Mateu-Rogell, Paloma Mateu-Rogell, Sandra Acevedo-Gallegos, Raigam Jafet Martinez-Portilla, Raigam Jafet Martinez-Portilla

    Published 2023-01-01
    “…Characteristics that significantly influenced PLGF were fetal crown rump length (CRL), maternal age, nulliparity, body mass index (BMI), chronic hypertension, Lupus, spontaneous pregnancy, polycystic ovary syndrome (PCOS), hypothyroidism, preeclampsia (PE) in a previous pregnancy, and mother with PE. …”
    Get full text
    Article
  2. 2242
  3. 2243

    Bilirubin Concentration in Follicular Fluid Is Increased in Infertile Females, Correlates with Decreased Antioxidant Levels and Increased Nitric Oxide Metabolites, and Negatively A... by Renata Mangione, Romina Pallisco, Gabriele Bilotta, Francesca Marroni, Valentina Di Pietro, Elena Capoccia, Giuseppe Lazzarino, Barbara Tavazzi, Giacomo Lazzarino, Pasquale Bilotta, Angela Maria Amorini

    Published 2023-06-01
    “…Using the same FF samples of this previous study, we here analyzed the FF concentrations of free and bound bilirubin and compared the results obtained in CFF, IF and the different subgroups of IF (endometriosis, EM, polycystic ovary syndrome, PCOS, age-related reduced ovarian reserve, AR-ROR, reduced ovarian reserve, ROR, genetic infertility, GI and unexplained infertility, UI). …”
    Get full text
    Article
  4. 2244
  5. 2245

    Metabolic Cytokines at Fasting and During Macronutrient Challenges: Influence of Obesity, Female Androgen Excess and Sex by M. Ángeles Martínez-García, Samuel Moncayo, María Insenser, Francisco Álvarez-Blasco, Manuel Luque-Ramírez, Héctor F. Escobar-Morreale

    Published 2019-10-01
    “…Methods: On alternate days we submitted 17 women with polycystic ovary syndrome (PCOS) (9 non-obese, 8 obese), 17 non-hyperandrogenic control women (9 non-obese, 8 obese) and 19 control men (10 non-obese, 9 obese) to isocaloric oral glucose, lipid and protein loads. …”
    Get full text
    Article
  6. 2246

    Hiperplasia adrenal congênita: dosagem da 17-hidroxiprogesterona basal para seleção e casos para realização do teste de estímulo com ACTH sintético Congenital adrenal hyperplasia:... by Lúcia Helena Coelho Nóbrega, Josivan Gomes de Lima, Maria Lúcia Coelho Nóbrega, Ana Luiza de Souza Brito, Raphael Pinto de Mendonça

    Published 2004-05-01
    “…Clinical presentation varies from life-threatening salt-losing adrenal hyperplasia to simple androgenic states, which can be of late-onset and very similar to polycystic ovary syndrome. Diagnosis is usually made by synthetic ACTH provocative tests but efforts are being made to simplify this investigation. …”
    Get full text
    Article
  7. 2247
  8. 2248

    Higher risk of pre-eclampsia and other vascular disorders with artificial cycle for frozen-thawed embryo transfer compared to ovulatory cycle or to fresh embryo transfer following... by Sylvie Epelboin, Julie Labrosse, Jacques De Mouzon, Aviva Devaux, Marie-José Gervoise-Boyer, Laetitia Hesters, Philippe Jonveaux, Rachel Levy, Nathalie Sermondade, Patricia Fauque, Fabienne Pessione

    Published 2023-05-01
    “…Results were adjusted for maternal characteristics and infertility (age, parity, smoking, obesity, history of diabetes or hypertension, endometriosis, polycystic ovary syndrome and premature ovarian insufficiency).ResultsA total of 68025 single deliveries were included: fresh-ET (n=48152), OC-FET (n=9500), AC-FET (n=10373). …”
    Get full text
    Article
  9. 2249

    Genotype, Mortality, Morbidity, and Outcomes of 3β-Hydroxysteroid Dehydrogenase Deficiency in Algeria by Asmahane Ladjouze, Malcolm Donaldson, Ingrid Plotton, Nacima Djenane, Kahina Mohammedi, Véronique Tardy-Guidollet, Delphine Mallet, Kamélia Boulesnane, Zair Bouzerar, Yves Morel, Florence Roucher-Boulez

    Published 2022-06-01
    “…Four girls reached menarche at 14.3 (11–14.5) years, with three developing adrenal masses (surgically excised in two) and polycystic ovary syndrome (PCOS), with radiological evidence of ovarian adrenal rest tumor in one. …”
    Get full text
    Article
  10. 2250
  11. 2251

    Homeostatic Model Assessment for Insulin Resistance Is Associated With Late Miscarriage in Non-Dyslipidemic Women Undergoing Fresh IVF/ICSI Embryo Transfer by Tianli Yang, Tianli Yang, Yuanyuan Yang, Yuanyuan Yang, Qiong Zhang, Qiong Zhang, Donge Liu, Donge Liu, Nenghui Liu, Nenghui Liu, Yumei Li, Yumei Li, Zhongyuan Yao, Zhongyuan Yao, Yeqing Zhang, Yeqing Zhang, Fen Tian, Fen Tian, Jing Zhao, Jing Zhao, Yanping Li, Yanping Li

    Published 2022-06-01
    “…Subgroup analysis based on presence or absence of the polycystic ovary syndrome (PCOS) status was also performed to analyze the effects of HOMA-IR among non-PCOS populations.ResultsThe late miscarriage rate and percentage of macrosomia increased with the HOMA-IR group (for late miscarriage rate: 2.23% vs. 3.04% vs. 7.35%, P<0.001; for macrosomia: 0.21% vs. 1.70% vs. 3.23%, P=0.002). …”
    Get full text
    Article
  12. 2252

    Risk of endometrial cancer in women treated with ovary-stimulating drugs for subfertility by Skalkidou, A, Sergentanis, T, Gialamas, S, Georgakis, M, Psaltopoulou, T, Trivella, M, Siristatidis, C, Evangelou, E, Petridou, E

    Published 2017
    “…This may largely be due to underlying risk factors in women who need treatment with clomiphene citrate, such as polycystic ovary syndrome, rather than exposure to the drug itself. …”
    Journal article
  13. 2253

    Exploration of molecular features of PCOS with different androgen levels and immune-related prognostic biomarkers associated with implantation failure by Qinyu Gao, Qinyu Gao, Qinyu Gao, Cong Ma, Cong Ma, Cong Ma, Shuyu Meng, Guanxiong Wang, Guanxiong Wang, Guanxiong Wang, Qiong Xing, Qiong Xing, Qiong Xing, Yuping Xu, Yuping Xu, Yuping Xu, Xiaojin He, Xiaojin He, Xiaojin He, Tianjuan Wang, Tianjuan Wang, Tianjuan Wang, Yunxia Cao, Yunxia Cao, Yunxia Cao

    Published 2022-08-01
    “…BackgroundPolycystic ovary syndrome (PCOS), the most common heterogeneous reproductive disease afflicting women of childbearing age, has been recognized as a chronic inflammatory disease recently. …”
    Get full text
    Article
  14. 2254

    AMH concentrations in infancy and mid-childhood predict ovarian activity in adolescence: A long-term longitudinal study of healthy girlsResearch in context by Casper P. Hagen, Margit Bistrup Fischer, Christine Wohlfahrt-Veje, Maria Assens, Alexander S. Busch, Anette Tønnes Pedersen, Anders Juul, Katharina M. Main

    Published 2023-01-01
    “…In contrast, patients with polycystic ovary syndrome (PCOS) have elevated AMH. The primary aim of this study was to evaluate the individual tracking of serum AMH concentrations, as well as whether AMH in early childhood reflects ovarian activity in adolescence. …”
    Get full text
    Article
  15. 2255

    Disease consequences of higher adiposity uncoupled from its adverse metabolic effects using Mendelian randomisation by Susan Martin, Jessica Tyrrell, E Louise Thomas, Matthew J Bown, Andrew R Wood, Robin N Beaumont, Lam C Tsoi, Philip E Stuart, James T Elder, Philip Law, Richard Houlston, Christopher Kabrhel, Nikos Papadimitriou, Marc J Gunter, Caroline J Bull, Joshua A Bell, Emma E Vincent, Naveed Sattar, Malcolm G Dunlop, Ian PM Tomlinson, Sara Lindström, INVENT consortium, Jimmy D Bell, Timothy M Frayling, Hanieh Yaghootkar

    Published 2022-01-01
    “…Here, MR with the FA and UFA genetics showed opposing effects on risk of disease: coronary artery disease, peripheral artery disease, hypertension, stroke, type 2 diabetes, polycystic ovary syndrome, heart failure, atrial fibrillation, chronic kidney disease, renal cancer, and gout. …”
    Get full text
    Article
  16. 2256
  17. 2257
  18. 2258

    Effect of Nutritional Supplementation on Oxidative Stress and Hormonal and Lipid Profiles in PCOS-Affected Females by Pallavi Dubey, Sireesha Reddy, Sarah Boyd, Christina Bracamontes, Sheralyn Sanchez, Munmun Chattopadhyay, Alok Dwivedi

    Published 2021-08-01
    “…Polycystic ovary syndrome (PCOS) affects several reproductive and endocrine features in females and has a poorly understood etiology. …”
    Get full text
    Article
  19. 2259

    Clinical Approaches to Nestorone Subdermal Implant Therapy in Women’s Health by Guilherme Renke, Consuelo Callizo, Raphaela Paes, Mariana Antunes, Glaycon Michels, Luana Concha, Ordânio Almeida, Christiane Valente, Thomaz Baesso, Bruna Giovannoni

    Published 2023-09-01
    “…In recent years, its potential uses in endometriosis, polycystic ovaries syndrome (PCOS), and a new therapeutic possibility for neuroprotection have made this treatment extremely interesting. …”
    Get full text
    Article
  20. 2260

    Implantation and Decidualization in PCOS: Unraveling the Complexities of Pregnancy by Satoko Matsuyama, Sarah Whiteside, Shu-Yun Li

    Published 2024-01-01
    “…Polycystic Ovary Syndrome (PCOS) is a prevalent endocrine disorder in women of reproductive age, affecting 5–15% globally with a large proportion undiagnosed. …”
    Get full text
    Article